Table 2.

Clinical characteristics, circulating levels of EPCs, and parameters charting the glycemic variability of 37 patients with type 1 diabetes (study 2)

Sex (male/female)	13/24
Age (years)	45 ± 13
BMI (kg/m2)	22.1 ± 2.7
Duration of diabetes (years)	11.2 ± 8.5
Treatment of insulin (MDI/CSII)	10/27
Fasting glucose	146.0 ± 62.6
GA (%)	21.7 ± 4.1
HbA1c (%)	7.5 ± 1.0
GA/HbA1c	2.89 ± 0.28
CPR (ng/ml)	0.12 ± 0.31
Microvascular complications (+/−)	6/31
Neuropathy (+/−)	3/34
Retinopathy (+/−)	2/35
Nephropathy (+/−)	3/34
Smoking status (+/−)	8/29
Hypertension (+/−)	10/27
Dyslipidemia (+/−)	13/24

Data are expressed as n (±) or mean ± SD

MDI multiple daily injections, CSII continuous subcutaneous insulin infusion, smoking status (+): current smoking, hypertension (+): blood pressure ≥130/80 mmHg, dyslipidemia (+): LDL-Chol ≥120 mg/dl and/or HDL-Chol <40 mg/dl and/or TG ≥150 mg/dl